Literature DB >> 1984863

L-arginine evokes both endothelium-dependent and -independent relaxations in L-arginine-depleted aortas of the rat.

V B Schini1, P M Vanhoutte.   

Abstract

This study was designed to investigate the effects of L-arginine (the substrate for the formation of endothelium-derived nitric oxide) in vascular tissues. Rat aortic rings, with or without endothelium, were suspended in organ chambers for the measurement of isometric tension; they were contracted with phenylephrine (10(-6) M). After a short incubation period (0.5 hour) in physiological salt solution, L-arginine induced minor changes in both types of rings. In contrast, when the incubation time was increased (2, 4, 6, and 8 hours), L-arginine evoked concentration- and time-dependent relaxations in aortic rings both with and without endothelium. The relaxations were larger in rings with endothelium. The presence of L-arginine (10(-3) M) in the incubation medium inhibited subsequent relaxations evoked by the amino acid. The concentration-relaxation curves associated with acetylcholine in rings with endothelium and the curves associated with Sin-1, a spontaneous donor of nitric oxide, in rings with or without endothelium were slightly but significantly shifted to the right after a 6-hour incubation. Nitro-L-arginine (3 x 10(-5) M) and methylene blue (3 x 10(-7) M) attenuated the relaxations evoked by L-arginine in rings both with and without endothelium. Other basic amino acids (D-arginine, L-homoarginine, L-citrulline, L-lysine, and L-ornithine; all tested at 10(-3) M) either had no effect or induced small relaxations and did not affect the response to L-arginine. These observations suggest that L-arginine specifically and stereoselectively relaxes aortic rings with and without endothelium, probably by restoring the endogenous pool of the amino acid, which is likely depleted by prolonged incubation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984863     DOI: 10.1161/01.res.68.1.209

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  18 in total

1.  R is for arginine: metabolism of arginine takes off again, in new directions.

Authors:  Thomas Michel
Journal:  Circulation       Date:  2013-09-04       Impact factor: 29.690

2.  Regulation of nitric oxide-like activity by prostanoids in smooth muscle of the canine saphenous vein.

Authors:  S Illiano; R Marsault; J J Descombes; T Verbeuren; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

3.  Role of iNOS in the vasodilator responses induced by L-arginine in the middle cerebral artery from normotensive and hypertensive rats.

Authors:  A M Briones; M J Alonso; J Marín; M Salaices
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

4.  Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.

Authors:  A S Adeagbo; C R Triggle
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

5.  Regulation of baseline vascular resistance in the canine diaphragm by nitric oxide.

Authors:  M E Ward; S N Hussain
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Superoxide and peroxynitrite in atherosclerosis.

Authors:  C R White; T A Brock; L Y Chang; J Crapo; P Briscoe; D Ku; W A Bradley; S H Gianturco; J Gore; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

7.  Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetized, open-chest dogs.

Authors:  V Richard; A Berdeaux; C D la Rochelle; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

8.  Attenuation of contractions to acetylcholine in canine bronchi by an endogenous nitric oxide-like substance.

Authors:  Y Gao; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

9.  L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.

Authors:  M A Creager; S J Gallagher; X J Girerd; S M Coleman; V J Dzau; J P Cooke
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  Aminoguanidine selectively inhibits inducible nitric oxide synthase.

Authors:  M J Griffiths; M Messent; R J MacAllister; T W Evans
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.